(Reuters) – The head of the U.S. Food and Drug Administration (FDA) is willing to fast-track a COVID-19 vaccine as quickly as possible, the Financial Times reported him as saying in an interview published on Sunday.
Stephen Hahn, who serves as the commissioner of FDA, said his agency was prepared to authorize a vaccine before Phase Three clinical trials were complete, the paper reported https://on.ft.com/3b8Uq8I.
(Reporting by Rebekah Mathew in Bengaluru, Editing by William Maclean)
